Features Archives - Page 6 of 15

715px-PARP1_binding_olaparib_5DS3 targeted protein degradation

Features

Another player emerges in the targeted protein degradation field

Targeted protein degradation is really taking off. Besides Arvinas, C4 Therapeutics, and Kymera, Cedilla Therapeutics, founded by Thirdrock Ventures, has emerged with a $56 million…

clement26.04.2018

Features

IP protection is crucial for business and research

The patent law and attorney-at-law firm Vossius & Partner has been an important partner for BaseLaunch since the inception of the healthcare accelerator in 2016.…

clement24.04.2018

Features

Little by Little: Real Life Lessons In Business Development

This blog was written by Tariq Kassum, COO and Head of Corporate Development at Obsidian Therapeutics, as part of the From The Trenches feature of…

clement17.04.2018

Features

Roivant launches new subsidiary in Basel

Our healthcare partner Roivant Sciences, a pharmaceutical company based in Basel, is launching Genevant with the Canadian Arbutus Biopharma Corporation. The aim of the new…

clement12.04.2018

Features

Roche grabs a remyelination MS drug from Versant as the research team spins out into a $25M regenerative med startup

Roche grabs a remyelination MS drug from Versant The Versant research team spins out into a $25M regenerative med startup Nearly 4 years after Roche…

clement04.04.2018

Features

Belldegrun teams with a group of top VC players to unveil a $295M biotech fund at Vida Ventures

Belldegrun teams with a group of top VC players to unveil a $295M biotech fund at Vida Ventures Belldegrun didn’t just co-found a new biotech…

clement03.04.2018

John Mcconnico | Bloomberg | Getty Images A lab technician at Pharma Novo Nordisk conducts in vitro research in Malov, Denmark.

Features

Big Pharma’s billion-dollar scramble to invest in start-ups to fuel innovation

Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation The worldwide prescription drug market is growing at 6.5% compounded annually and is expected…

clement29.03.2018

Features

BioMedPartners closes new venture capital fund

Basel-based venture capitalist firm BioMedPartners has closed its new venture capital fund BioMedInvest III at 100 million Swiss francs. The fund will help drive growth…

clement06.03.2018

Features

Startup Generation Bio builds alternative to potentially risky viral vectors

A gene therapy startup company The startup headed up by bigwigs and backed early on by Atlas has pulled in a mega-round of $100 million. The…

clement27.02.2018

Features

One year BaseLaunch healthcare accelerator program – Happy Birthday!

A short review A year ago, BaselArea.swiss presented BaseLaunch at a fully booked launch event in Basel, Switzerland. Guests from the healthcare industry, research, academia…

clement22.02.2018

Features

Another player emerges in the targeted protein degradation field

IP protection is crucial for business and research

Little by Little: Real Life Lessons In Business Development

Roivant launches new subsidiary in Basel

Roche grabs a remyelination MS drug from Versant as the research team spins out into a $25M regenerative med startup

Belldegrun teams with a group of top VC players to unveil a $295M biotech fund at Vida Ventures

Big Pharma’s billion-dollar scramble to invest in start-ups to fuel innovation

BioMedPartners closes new venture capital fund

Startup Generation Bio builds alternative to potentially risky viral vectors

One year BaseLaunch healthcare accelerator program – Happy Birthday!

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us